Development of delirium model |
Choose species, include both sexes.
Choose delirium feature(s) to study, recognizing that high-fidelity models that mimic human delirium are not yet available.
Consider face and construct validity in development of model (ie, appropriate age, vulnerability, and precipitating factors [Table 2])
Consider behavioral test(s) and frequency to mimic components of delirium in humans (Table 3).
Multiple animal models with different precipitants across different settings maybe required for cross-validation.
Carefully control for confounding factors (appetitive, motivational, locomotor, stress-related, illness-induced) that could be inappropriately conflated with delirium-like effects
Adhere to current standards for ethical treatment of animals
|
Experimental framework |
Appropriate blinding and randomization of outcome assessments
Reproducibility, which requires standardization of protocols and adequate sample sizes
Monitoringand physiological control of perturbations, especially anesthesia and infection
Standardization of behavioral protocols
Consideration of temporal alignment of pathophysiology and behavior
|
Validation of animal model |
Cross-validation of behavioral changes with both human and animal biomarkers (eg, biofluid, EEG, imaging)
Testing of animal responses to efficacious pharmacological and nonpharmacological human interventions
|
Reporting of animal studies |
Adherence to PREPARE guidelines119
Standardization and protocol validation
Data deposition in publicly accessible databases
|
Future research priorities |
Iterative testing and cross-translation of animal models and human delirium to optimize models, clarify pathophysiological mechanisms, and develop and test therapeutics
Large-scale collaborative studies to develop, standardize, and validate animal models for delirium; subsequent alignment with human studies as data become available
|